Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA bupr...
FY 2026
Apr 29, 2026
Q4 2026
Q3 2026
Dec 11, 2025
Q2 2026
Sep 9, 2025
Q1 2026
May 30, 2025